Accreditation and Designation User Manual - OECI

More documents

Recommendations

Info

Send signed accreditation and designation agreement Executor: Cancer institute The AD Agreement shall be signed by the Director/Board of Directors of the cancer institute and sent to the A&D Secretary. The A&D Secretary will manage to complete the A&D Agreement with the signatures of the OECI A&D Chair and of the OECI President. Preparation of explanatory visit Executor: OECI Accreditation Coordinator The OECI A&D Coordinator: − Receives the confirmation of the explanatory visit date and the signed A&D agreement from the institute (or OECI Secretary), − Drafts the concept explanatory agenda for the cancer institute (doc 7), − Sends the concept agenda to the (cancer) institute to complete the agenda with the participants (doc. 7), − Sends the template project plan (doc 05) as an example on how to organise the self-assessment period in the institute. Accommodation and transport for the explanatory visit are booked by the delegates of the OECI A&D Group. Owner: OECI Organisation of European Cancer Institutes Status: Revised - 24 th January 2011 - A&D Working Group Approved by: OECI Accreditation and Designation Board Chapter 5 Ten steps A&D process in detail Page 6 of 28 Version 16 February 2011
5.2 Step 2: Payment stage 1 fee The institute receives the first payment order after approval of the application and the designation screening, and before the explanatory visit. Tasks of the Executive Manager: − Sending invoices to the institutes including the signed A&D Agreement − Controlling the payments of the institutes, − Providing the A&D Chair and A&D Secretary with a copy of invoices sent to the institutes. Tasks of the A&D Secretary: − Confirming payments of the institutes to the institute and Executive Manager. The total fee depends on the designation type of the institute: Stage 1 Stage 2 Total Cancer Unit € 5.000 € 15.000 € 20.000 Clinical Cancer Centre € 5.000 € 25.000 € 30.000 Comprehensive Cancer Centre (CCC) € 5.000 € 25.000 € 30.000 The fee of stage one is equal for all types of institutes and covers primarily the costs for application and designation screening, explanatory visit, use of the e-tool during the self-assessment period, the OECI support during the self-assessment period, the organisation of meetings for the A&D Committee and A&D Board for the ‘go’ decision, and labour costs of the A&D Management Unit. Difference in fee − The peer review visit in a Cancer Unit possibly takes one day instead of two full days in clinical cancer centres and CCC’s, − The peer review visit in a Cancer Unit does not include the full set of standards. Standards related to chapter 4 ‘Research, innovation and development’ are not assessed, − The audit team possibly includes less than four auditors. Note: There might be reasons for an institute not being able to continue the A&D programme towards the peer review visit after the self-assessment, such as: delay of the self-assessment period, ‘no go’ decision, changes in the management of the institutes etc. One year after the payment of stage 1 an institute will be reminded of its participation in the programme. The application of the institute will expire if the institute will not continue the programme within two years after the payment of stage 1. The OECI A&D Group will not return the payment of stage 1. Note: If there is a discrepancy between the designation judgement of the institute and the preliminary designation that remains after the explanatory visit, the institute shall pay the fee equal to the designation type applied for. For example: an institute that has classified itself as a clinical cancer centre and is willing to continue the programme as such, shall pay in total € 30.000 although the preliminary designation is a cancer unit. Note: If an institute decides to apply for A&D as clinical cancer centre or CCC the full set of standards will be assessed, including the standards related to chapter 4 ‘Research, innovation and development’. Owner: OECI Organisation of European Cancer Institutes Status: Revised - 24 th January 2011 - A&D Working Group Approved by: OECI Accreditation and Designation Board Chapter 5 Ten steps A&D process in detail Page 7 of 28 Version 16 February 2011
Page 1: ORGANISATION OF EUROPEAN CANCER INS
Page 4 and 5: OECI Accreditation and Designation
Page 6 and 7: THE OECI Accreditation and Designat
Page 8 and 9: Owner: OECI Organisation of Europea
Page 10 and 11: The keyword in the designation of E
Page 12 and 13: 2.1.1 General explanation of the te
Page 14 and 15: OECI General Assembly Member Instit
Page 16 and 17: − Organizing the auditors’ meet
Page 18 and 19: 3.2 Audit team and auditors 3.2.1 O
Page 20 and 21: 3.3 Cancer institute Obviously all
Page 24 and 25: 5.1.1 Step 1: activities and respon
Page 26 and 27: Designation questionnaire Executor:
Page 30 and 31: 5.3 Step 3: Explanatory visit and p
Page 34 and 35: Finishing self-assesment Executor:
Page 36 and 37: 5.6 Step 6: Payment stage 2 fee If
Page 38 and 39: Preparation of the auditors’ team
Page 40 and 41: Performing the peer review Executor
Page 42 and 43: 5.8.1 Week 1-6: Reporting by the au
Page 46 and 47: 5.9 Step 9: Formulate improvement p
Page 48 and 49: 5.10.1 Evaluation of the A&D Progra
Page 50 and 51: Intermediate self-assessment (optio
Page 58 and 59: 2 / OECI Accreditation and Designat
Page 60 and 61: Qualitative Questionnaire 1. Genera
Page 62 and 63: 1.3.2. Administration of cytostatic
Page 64 and 65: 1.4.6. Roles and tasks of the membe
Page 66 and 67: 1.4.12. Registration and evaluation
Page 68 and 69: 1.5.5. Quality assurance in all are
Page 70 and 71: 2.4.5. Smoking control in the cance
Page 72 and 73: 3.4.4. Palliative and terminal care
Page 74 and 75: 4. Research, innovation and develop
Page 76 and 77: 4.3. Resources and materials 4.3.1.
Page 78 and 79:
5. Teaching and continuing educatio
Page 80 and 81:
6. Patient related 6.4. Process con
Page 82 and 83:
6.5. Safeguarding the quality syste
Page 84 and 85:
1.4.7. at national level at regiona
Page 86 and 87:
2.3. Infrastructures with a focus o
Page 88 and 89:
2.9. Radiology 2.9.1. Number of CT
Page 90 and 91:
2.15. Facilities 2.15.1. On site Ac
Page 92 and 93:
3.4. Human resources (4) 3.4.1. Pat
Page 94 and 95:
4.3. Structures 4.3.1. Yes No not a
Page 96 and 97:
5. Education 5.1. Education 5.1.1.
Page 98 and 99:
Planning of the project Start Expla
Page 100 and 101:
Go to the qualitative and quantitat
Page 102 and 103:
3. Before moving to the next item p
Page 104 and 105:
The following screen will appear. F
Page 106 and 107:
• Close the questionnaire if you
Page 108 and 109:
Print only the questions or the ful
Page 110 and 111:
Workspace: Go to the questionnaires
Page 112 and 113:
2. Preparing a peer review Open a q
Page 114 and 115:
To view the remarks and the score o
Page 116 and 117:
2 / OECI Accreditation and Designat
Page 118 and 119:
Qualitative Questionnaire 1. Genera
Page 120 and 121:
1.3.2. Administration of cytostatic
Page 122 and 123:
1.4.6. Roles and tasks of the membe
Page 124 and 125:
1.4.12. Registration and evaluation
Page 126 and 127:
1.5.5. Quality assurance in all are
Page 128 and 129:
2.4.5. Smoking control in the cance
Page 130 and 131:
3.4.4. Palliative and terminal care
Page 132 and 133:
4. Research, innovation and develop
Page 134 and 135:
4.3. Resources and materials 4.3.1.
Page 136 and 137:
5. Teaching and continuing educatio
Page 138 and 139:
6. Patient related 6.4. Process con
Page 140 and 141:
6.5. Safeguarding the quality syste
Page 142 and 143:
1.4.7. at national level at regiona
Page 144 and 145:
2.3. Infrastructures with a focus o
Page 146 and 147:
2.9. Radiology 2.9.1. Number of CT
Page 148 and 149:
2.15. Facilities 2.15.1. On site Ac
Page 150 and 151:
3.4. Human resources (4) 3.4.1. Pat
Page 152 and 153:
4.3. Structures 4.3.1. Yes No not a
Page 154 and 155:
5. Education 5.1. Education 5.1.1.
Page 156 and 157:
Planning of the project Start Expla
Page 158 and 159:
Go to the qualitative and quantitat
Page 160 and 161:
3. Before moving to the next item p
Page 162 and 163:
The following screen will appear. F
Page 164 and 165:
• Close the questionnaire if you
Page 166 and 167:
Print only the questions or the ful
Page 168 and 169:
Workspace: Go to the questionnaires
Page 170 and 171:
2. Preparing a peer review Open a q
Page 172:
To view the remarks and the score o
show all

Accreditation and Designation User Manual - OECI

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?